For example, for outpatients or resource-limited settings with a moderate probability 4-T score (but low clinical suspicion), would you ever consider waiting for HIT testing before changing to nonheparinoid agent. Or would you switch a patient to immediately (to a DOAC or fondaparinux) given the risk?